Description: Seer, Inc., a life sciences company, engages in developing nanoparticle technology solutions for researchers in the areas of proteomics information. The company develops Proteograph, an integrated solution comprising consumables, automation instrumentation, and proprietary software that performs proteomics analysis. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is based in Redwood City, California.
Home Page: seer.bio
SEER Technical Analysis
3800 Bridge Parkway
Redwood City,
CA
94065
United States
Phone:
650 453 0000
Officers
| Name | Title |
|---|---|
| Dr. Omid C. Farokhzad M.D., Ph.D. | Founder, Pres, CEO & Chair of the Board of Directors |
| Mr. David R. Horn | Exec. VP, Treasurer & CFO |
| Ms. Elona Kogan Esq., J.D. | Gen. Counsel & Sec. |
| Mr. Joe Laws | Chief Technology Officer and Co-Founder |
| Kenny Ross | Chief Operations & Product Officer |
| Ms. Karen Possemato | Chief Marketing Officer |
| Ms. Marissa Dixon | Chief People Officer |
| Dr. Serafim Batzoglou Ph.D. | Chief Data Officer |
| Mr. Martin Goldberg Ph.D. | Sr. VP of Devel. |
| Mr. Scott D. Thomas | Chief Commercial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8539 |
| Price-to-Sales TTM: | 28.3714 |
| IPO Date: | 2020-12-04 |
| Fiscal Year End: | December |
| Full Time Employees: | 118 |